Concurrent Investment Advisors’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Sell
101,068
-2,782
-3% -$18.4K 0.01% 1290
2026
Q1
$538K Buy
103,850
+798
+0.8% +$4.99K 0.01% 1183
2025
Q4
$753K Buy
103,052
+24,197
+31% +$234K 0.01% 958
2025
Q3
$786K Buy
78,855
+28,048
+55% +$310K 0.01% 739
2025
Q2
$460K Sell
50,807
-25,312
-33% -$165K 0.01% 880
2025
Q1
$489K Buy
76,119
+3,569
+5% +$31.8K 0.01% 760
2024
Q4
$690K Buy
72,550
+32,027
+79% +$281K 0.02% 584
2024
Q3
$331K Buy
40,523
+3,857
+11% +$40.1K 0.01% 744
2024
Q2
$496K Buy
+36,666
New +$307K 0.02% 587

Other funds holding ENVX

Concurrent Investment Advisors's ENVX Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Enovix (ENVX) stake by 2.7% in Q2 2026, selling an estimated $18.4K and leaving 101,068 shares worth $613K. The position accounts for 0.01% of the portfolio, ranked #1290.

Concurrent Investment Advisors first reported a position in ENVX in Q2 2024 and has held it in 9 quarters since. The position peaked at $786K in Q3 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Concurrent Investment Advisors held 101,068 shares of Enovix worth $613K as of Q2 2026.
  • Concurrent Investment Advisors sold 2,782 Enovix shares in Q2 2026, an estimated $18.4K.
  • Enovix made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1290 holding.
  • Concurrent Investment Advisors first reported a position in Enovix in Q2 2024 and has held it in 9 quarters since.
  • Concurrent Investment Advisors's Enovix position peaked at $786K in Q3 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.